February 2026
Learning Objectives
By completing this eLearning module:
- Improve HCP’s understanding of the updated practice guidelines for the topical treatment of pediatric atopic dermatitis
- Clinicians have enhanced understanding of the role and mechanism of action of topic therapies to tailor treatment plans as per the patient profile
- HCPs gain greater confidence and appreciation of the residual risks of therapy to patients even with the latest standard-of-care therapies
Activity Disclosures
This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.
Disclaimer
Dr. Adelaide Hebert has had research grants paid to UTHealth from Pfizer, Arcutis, Dermavant/Organaon, Amgen, AbbVie, Incyte, Janssen, Oneness, Takeda; honoraria for consulting, speaking or serving on a DSMB from Pfizer, Arcutis, Dermavant/Organaon, Incyte, Ortho – Dermatologics, Sanofi Regeneron, Incyte, Takeda, Lilly, Sun Pharma, Pelthos, Apogee, Galderma.
Dr. Matthew Zirwas has served as a consultant, speaker and/or investigator for: AbbVie, Acrotech, Advanced Derm Solutions, Aldeyra, Henkel, Amgen, Anaptys Bio, Apogee, Arcutis, Beiersdorf, Biocon, Boehringer, Bristol Myers Squibb, Cara, Celldex, Organon, Evelo, Evommune, Galderma, Google, Incyte, Janssen, L’Oreal, Leo, Lilly, LUUM, Meta, Nimbus, Novartis, Pelthos, Pfizer, Q32 Bio, Regeneron, Sanofi, Sun, Supernus, Takeda, UCB, Verrica, Zai Labs
This activity underwent review in line with standards of editorial integrity and publication ethics. Potential conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest. The primary resolution method was review by an unconflicted expert. For information about the accreditation of this program, please contact [email protected].
Accreditation
John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
John Wiley and Sons, Inc. designates this enduring material based CME activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within 30 minutes and complete the activity during the valid credit period, which is up to three years from initial publication. Additionally, up to 3 attempts and a score of 70% or higher is needed to pass the post-test and claim credit. You will need to log into your Wiley Health Learning account (registration is free) to complete this activity and earn a certificate.
To begin, please click the Pre-test button below to contribute to our outcomes data then proceed to the course content.
